Akshay Rajan Raheja (Promoter) increased their stake in Innovassynth Technologies (India) Limited from 24.86% to 25.42% by purchasing 48,45,873 shares for ₹33.44 Cr at ₹69.01 apiece through a rights issue.
A Contract Research, Development and Manufacturing Organization specializing in pharmaceutical intermediates, oligonucleotide building blocks, and specialty chemicals for global markets. Incorporated in 2008, the company provides custom synthesis and manufacturing solutions to pharmaceutical and biotechnology clients worldwide. Its technical expertise in niche chemical segments and vertically integrated capabilities distinguish it within India's pharmaceutical and chemical manufacturing sector.
